GlassScriptPhysician profile
Wayne I Tucker
NPI 1356430821
$19,521.24
in general payments reported to CMS, 2019-2025
56 companies · $2,804 in 2025
The $2,804 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,258 · 2020: $2,706 · 2021: $3,030 · 2022: $2,590 · 2023: $3,385 · 2024: $2,748 · 2025: $2,804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,936.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,985.44 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $2,372.08 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $1,419.50 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,343.63 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $1,306.83 | 2021-2025 | Qulipta, Ubrelvy, Vraylar |
| Kowa Pharmaceuticals America, INC. | $1,162.19 | 2019-2025 | Livalo, Seglentis, Zoryve |
| Lilly USA, LLC | $1,030.42 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $641.91 | 2019-2025 | Repatha, Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $599.36 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $594.40 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $409.51 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $396.47 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Astellas Pharma US INC | $367.76 | 2019-2025 | Veozah, Myrbetriq |
| Corcept Therapeutics | $357.69 | 2025 | Korlym |
| Xeris Pharmaceuticals, INC. | $327.69 | 2021-2023 | Gvoke Hypopen |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $318.20 | 2019-2022 | |
| Abbott Laboratories | $295.76 | 2022-2025 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $272.79 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $262.40 | 2020-2025 | Rexulti |
| Jazz Pharmaceuticals INC. | $228.43 | 2020-2022 | |
| Amarin Pharma, INC. | $219.56 | 2019-2022 | |
| Esperion Therapeutics, INC. | $217.62 | 2020-2025 | Nexletol |
| Sunovion Pharmaceuticals INC. | $208.53 | 2019-2022 | |
| Exact Sciences Corporation | $161.21 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Medtronic, INC. | $156.68 | 2023 | Interstim, Intellis Adaptivestim |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $143.73 | 2024-2025 | Caplyta |
| Dexcom, INC. | $139.74 | 2023-2025 | Dexcom G6 Transmitter |
| Eisai INC. | $138.21 | 2020-2022 | |
| Allergan, INC. | $125.27 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $122.84 | 2020-2024 | Glassia |
| Horizon Therapeutics Plc | $116.08 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $104.37 | 2025 | Fanapt, Hetlioz |
| Insulet Corporation | $92.54 | 2021-2023 | Omnipod |
| Alkermes, INC. | $87.05 | 2019-2024 | Vivitrol, Vivitrol |
| Idorsia Pharmaceuticals US INC | $82.77 | 2023-2024 | Quviviq |
| Currax Pharmaceuticals LLC | $80.40 | 2021-2024 | Contrave, Onzetra Xsail |
| Biohaven Pharmaceuticals, INC. | $76.97 | 2021 | |
| Corium, LLC | $75.89 | 2022-2023 | Azstarys |
| Axsome Therapeutics, INC. | $75.63 | 2022-2023 | Sunosi |
| Alk-Abello, INC | $50.21 | 2025 | Grastek, Odactra, Ragwitek |
| Phathom Pharmaceuticals, INC. | $42.70 | 2024-2025 | Voquezna |
| Supernus Pharmaceuticals, INC. | $39.48 | 2022-2023 | Qelbree |
| Biohaven Pharmaceutical Holding Company LTD. | $33.11 | 2022 | |
| Tactile Systems Technology INC | $32.88 | 2025 | Nimbl, Flexitouch Plus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.37 | 2024-2025 | Xifaxan |
| Almatica Pharma LLC | $28.72 | 2023 | Gralise, Sertraline Hcl, Loreev Xr |
| Sanofi Pasteur INC. | $19.91 | 2023 | |
| Genentech USA, INC. | $17.55 | 2021 | |
| Lundbeck LLC | $15.85 | 2022 | |
| Shire North American Group INC | $14.39 | 2019 | |
| Hikma Pharmaceuticals USA | $14.18 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $13.96 | 2022 | |
| Strongbridge US INC. | $13.94 | 2019 | |
| Antares Pharma, INC. | $12.51 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.18 | 2019 | |
| Cequr Corporation | $9.75 | 2024 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.